873 related articles for article (PubMed ID: 18780260)
1. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India.
Gharai S; Venkatesh P; Garg S; Sharma SK; Vohra R
Ophthalmic Epidemiol; 2008; 15(4):264-71. PubMed ID: 18780260
[TBL] [Abstract][Full Text] [Related]
2. Ocular manifestations of HIV infection.
Jabs DA
Trans Am Ophthalmol Soc; 1995; 93():623-83. PubMed ID: 8719695
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of ocular manifestations and blindness in HIV/AIDS patients on HAART in a tertiary care hospital in western India.
Shah SU; Kerkar SP; Pazare AR
Br J Ophthalmol; 2009 Jan; 93(1):88-90. PubMed ID: 18952644
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
[TBL] [Abstract][Full Text] [Related]
5. Seven years of HAART impact on ophthalmic management of HIV-infected patients.
Kahraman G; Krepler K; Franz C; Ries E; Maar N; Wedrich A; Rieger A; Dejaco-Ruhswurm I
Ocul Immunol Inflamm; 2005; 13(2-3):213-8. PubMed ID: 16019681
[TBL] [Abstract][Full Text] [Related]
6. [Ocular manifestations in patients with human immunodeficiency virus infection before and after the introduction of highly active antiretroviral therapy].
Mesarić B; Lisić M; Kniewald T; Ugrinović N; Begovac J
Lijec Vjesn; 2005; 127(5-6):123-8. PubMed ID: 16281473
[TBL] [Abstract][Full Text] [Related]
7. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis.
Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK
Am J Ophthalmol; 2005 Jun; 139(6):1028-34. PubMed ID: 15953432
[TBL] [Abstract][Full Text] [Related]
8. Impact of highly active antiretroviral therapy on cytomegalovirus viraemia in the absence of specific anti-cytomegalovirus therapy.
Mihăilescu R; Arama V; Paraschiv S; Streinu-Cercel A; Oţelea D; Munteanu D; Iosipenco M; Chiotan C; Benea OE; Mărdărescu M; Rădulescu M; Hristea A; Ungurianu R; Aramă SS; Cercel AS; Călin R; Băicuş C
Rom J Intern Med; 2008; 46(4):305-11. PubMed ID: 19480296
[TBL] [Abstract][Full Text] [Related]
9. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
Retina; 2000; 20(2):151-5. PubMed ID: 10783947
[TBL] [Abstract][Full Text] [Related]
10. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
[TBL] [Abstract][Full Text] [Related]
11. Ophthalmic manifestations and risk factors for mortality of HIV patients in the post-highly active anti-retroviral therapy era.
Lai TY; Wong RL; Luk FO; Chow VW; Chan CK; Lam DS
Clin Exp Ophthalmol; 2011 Mar; 39(2):99-104. PubMed ID: 20796263
[TBL] [Abstract][Full Text] [Related]
12. Ocular complications of human immunodeficiency virus infection in eastern china.
Wang Z; Jia R; Ge S; He T; Zhang Y; Yang Y; Wang Y; Shi W; Ji Y; Ye F; Chen P; Lu J; Sun J; Xu X; Zhou Y; Gu P; Luo M; Lu H; Fan X
Am J Ophthalmol; 2012 Feb; 153(2):363-369.e1. PubMed ID: 21982101
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis and treatment of eye diseases associated with HIV infection and AIDS].
Geng S; Ye JJ; Liu LQ; Xu HY; Wang WW; Wang SR
Zhonghua Yan Ke Za Zhi; 2009 Dec; 45(12):1093-8. PubMed ID: 20193432
[TBL] [Abstract][Full Text] [Related]
14. Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Thorne JE; Jabs DA; Kempen JH; Holbrook JT; Nichols C; Meinert CL;
Ophthalmology; 2006 Aug; 113(8):1441-5. PubMed ID: 16781775
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection.
Kuo IC; Kempen JH; Dunn JP; Vogelsang G; Jabs DA
Am J Ophthalmol; 2004 Sep; 138(3):338-46. PubMed ID: 15364214
[TBL] [Abstract][Full Text] [Related]
16. Proliferative vitreoretinopathy in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Kunavisarut P; Bijlsma WR; Pathanapitoon K; Patikulsila D; Choovuthayakorn J; Rothova A
Am J Ophthalmol; 2010 Aug; 150(2):218-22. PubMed ID: 20525529
[TBL] [Abstract][Full Text] [Related]
17. Ophthalmic manifestation of aids in Armed Forces General Teaching Hospital, Addis Ababa.
T/Giorgis A; Melka F; G/Mariam A
Ethiop Med J; 2007 Oct; 45(4):327-34. PubMed ID: 18326342
[TBL] [Abstract][Full Text] [Related]
18. HIV-associated retinopathy in the HAART era.
Goldberg DE; Smithen LM; Angelilli A; Freeman WR
Retina; 2005; 25(5):633-49; quiz 682-3. PubMed ID: 16077362
[TBL] [Abstract][Full Text] [Related]
19. Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Thorne JE; Jabs DA; Kempen JH; Holbrook JT; Nichols C; Meinert CL;
Ophthalmology; 2006 Aug; 113(8):1432-40. PubMed ID: 16766032
[TBL] [Abstract][Full Text] [Related]
20. Effect of highly active antiretroviral therapy (HAART) on the natural history of ocular manifestations in HIV-infected children.
Esposito S; Porta A; Bojanin J; Gualtieri L; Cesati L; Vismara E; Principi N
Eye (Lond); 2006 May; 20(5):595-7. PubMed ID: 16410815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
